---
figid: PMC5008283__oncotarget-07-21259-g001
figlink: /pmc/articles/PMC5008283/figure/F1/
number: Figure 1
caption: RCC is a highly vascularized tumor type. The chronic angiogenesis is required
  for growth of these tumors. Under normal conditions HIF (hypoxia inducible factor)
  is constitutively degraded. HIF promotes transcription of gene involved in the angiogenesis-pathway
  and tumor progression such as VEGF, PDGF and TGF-alfa. Inactivation of the von Hippel-Lindau
  (VHL) gene leads to accumulation of HIF transcription factors and subsequent activation
  of several mediator of angiogenesis. Also the activation of the mammalian target
  of rapamycin (mTOR) signaling pathway may result in HIF accumulation. Temsirolimus
  and everolimus are kinase inhibitors of mTOR complex 1 (mTORC1); bevacizumab is
  a humanized anti-VEGF monoclonal antibody; sorafenib, sunitinib, pazopanib and axitinib
  are multikinase inhibitor (TKIs) of growth factor receptors involved in the activation
  of angiogenesis-related pathways.
pmcid: PMC5008283
papertitle: 'Beyond evidence-based data: scientific rationale and tumor behavior to
  drive sequential and personalized therapeutic strategies for the treatment of metastatic
  renal cell carcinoma.'
reftext: Lorena Incorvaia, et al. Oncotarget. 2016 Apr 19;7(16):21259-21271.
pmc_ranked_result_index: '121546'
pathway_score: 0.9345762
filename: oncotarget-07-21259-g001.jpg
figtitle: 'Beyond evidence-based data: scientific rationale and tumor behavior to
  drive sequential and personalized therapeutic strategies for the treatment of metastatic
  renal cell carcinoma'
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5008283__oncotarget-07-21259-g001.html
  '@type': Dataset
  description: RCC is a highly vascularized tumor type. The chronic angiogenesis is
    required for growth of these tumors. Under normal conditions HIF (hypoxia inducible
    factor) is constitutively degraded. HIF promotes transcription of gene involved
    in the angiogenesis-pathway and tumor progression such as VEGF, PDGF and TGF-alfa.
    Inactivation of the von Hippel-Lindau (VHL) gene leads to accumulation of HIF
    transcription factors and subsequent activation of several mediator of angiogenesis.
    Also the activation of the mammalian target of rapamycin (mTOR) signaling pathway
    may result in HIF accumulation. Temsirolimus and everolimus are kinase inhibitors
    of mTOR complex 1 (mTORC1); bevacizumab is a humanized anti-VEGF monoclonal antibody;
    sorafenib, sunitinib, pazopanib and axitinib are multikinase inhibitor (TKIs)
    of growth factor receptors involved in the activation of angiogenesis-related
    pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3R5
  - PIK3R4
  - PIK3R6
  - AKT3
  - AKT2
  - ARNT
  - PIK3CD
  - VEGFC
  - VHL
  - PIK3CB
  - HIF1A
  - HIF3A
  - ARNT2
  - PDGFA
  - ARNTL
  - AKT1
  - PTEN
  - EPAS1
  - VEGFB
  - PDGFD
  - PDGFC
  - PIK3CG
  - PIK3R3
  - PGF
  - VEGFD
  - VEGFA
  - PDGFB
  - Temsirolimus
  - Pazopanib
  - Cancer
genes:
- word: PI3.K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3.K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3.K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3.K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: PI3.K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: PI3.K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: PI3.K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3.K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Pazopanib
  source: MESH
  identifier: C516667
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
